Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.AU |
First Approval Date01 Oct 1996 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date26 Sep 1996 |
Phase III study combined with post-marketing clinical study of RM1319 in patients with inborn errors of bile acid metabolism, including children - Phase III study combined with post-marketing clinical study of RM1319 in patients with inborn errors of bile acid metabolism, including children
Safety study of NaPPS in pediatric patients with mucopolysaccharidosis type VI
Safety study of NaPPS in pediatric patients with mucopolysaccharidosis type VI
100 Clinical Results associated with ReqMed Co., Ltd.
0 Patents (Medical) associated with ReqMed Co., Ltd.
Carrer path. Novartis/biocamp: dream, challenge and presure
Author: Matsumoto, Tadashi
Come over Inter-college, Bioseries
Author: Matsumoto, Tadashi
New encounter especially when things were bad
100 Deals associated with ReqMed Co., Ltd.
100 Translational Medicine associated with ReqMed Co., Ltd.